Strati et al. reported that the PD-L1 expression level of circulating tumor cells in the peripheral blood of patients with head and neck squamous cell carcinoma is related to the patient’s response to PD-L1 inhibitor therapy (31). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.